NACHUM SHAMIR
CIK 1622164 · President & CEO · last filed 2026-07-01
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$960.4K
Companies
6
Total Filings
36
Lifetime Open-Market Net
-$16.69M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| STXS | Director | 179,327 | $1.28 | $229.5K | $0 | 4 | 2026-07-01 |
| MDWD | Director | 49,990 | $14.62 | $730.9K | $84.0K | 1 | 2026-06-04 |
| STRATA Skin Sciences, Inc. (SSKN) Delisted | Director | 28,987 | $0.15 | $4.3K | $103.7K | 6 | 2023-07-07 |
| IsoPlexis Corp (ISO) Delisted | Director | 0 | $0.76 | $0 | $97.1K | 3 | 2023-03-21 |
| LMNX | President & CEO | 0 | $14.10 | $0 | -$16.98M | 19 | 2021-07-15 |
| CGNT | Director | 0 | $8.92 | $0 | $0 | 3 | 2018-04-23 |
Recent Filings · Page 2 of 4
36 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2021-09-09 | STRATA Skin Sciences, Inc. (SSKN) Delisted | Buy (P) | +71,420 | $103.7K | EDGAR |
| 2021-07-21 | STRATA Skin Sciences, Inc. (SSKN) Delisted | Grant (A) | +61,297 | $0 | EDGAR |
| 2021-07-15 | LMNX | Disp (D) | −241,170 | -$8.92M | EDGAR |
| 2021-03-15 | LMNX | Mixed | +50,628 | $1.66M | EDGAR |
| 2020-08-05 | LMNX | Mixed | — | -$5.77M | EDGAR |
| 2020-04-16 | LMNX | Mixed | — | -$2.35M | EDGAR |
| 2020-03-13 | LMNX | Mixed | −8,859 | -$211.3K | EDGAR |
| 2019-11-26 | STRATA Skin Sciences, Inc. (SSKN) Delisted | Grant (A) | +16,260 | $0 | EDGAR |
| 2019-11-12 | LMNX | Buy (P) | +5,000 | $96.5K | EDGAR |
| 2019-08-27 | LMNX | Buy (P) | +5,000 | $98.5K | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.